# Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm

> **NCT01433809** · — · COMPLETED · sponsor: **Norman Eberhardt** · enrollment: 1 (actual)

## Conditions studied

- Cancer of the Thyroid
- Neoplasms, Thyroid
- Thyroid Adenoma
- Thyroid Cancer
- Thyroid Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01433809
- **Lead sponsor:** Norman Eberhardt
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2014-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01433809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01433809, "Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01433809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*